Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study.
about
Shigella Vaccine Development: Finding the Path of Least Resistance.Functional and Antigen-Specific Serum Antibody Levels as Correlates of Protection against Shigellosis in a Controlled Human Challenge Study.Human immune responses against Shigella and enterotoxigenic E. coli: Current advances and the path forward.Vaccinomics Approach for Designing Potential Peptide Vaccine by Targeting Shigella spp. Serine Protease Autotransporter Subfamily Protein SigAA Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against Shigella sonnei Administered Intramuscularly to Adults from a Shigellosis-Endemic Country.Potential targets for next generation anti-microbial glycoconjugate vaccines.A recombinant conjugated pneumococcal vaccine that protects against murine infections with a similar efficacy to Prevnar-13
P2860
Q37477191-29D6DB23-5224-4715-BDAB-876857B6CC5EQ37633069-A216823C-48B3-4033-9B71-AB1286433333Q40192692-C91BCC8F-C3F4-4DEB-BC22-571651FC288BQ42730634-B560E706-1876-4D95-8023-5FB9921970AFQ49210830-4C93F31A-2BF3-4C04-8347-40D40D76255CQ53701548-E05ED0B4-56D2-4DEE-A25C-E705E91837D7Q58587115-BDD8545F-F736-4B1E-80CD-184E848EB2DC
P2860
Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Safety and Immunogenicity of a ...... ind, Randomized Phase I Study.
@en
Safety and Immunogenicity of a ...... ind, Randomized Phase I Study.
@nl
type
label
Safety and Immunogenicity of a ...... ind, Randomized Phase I Study.
@en
Safety and Immunogenicity of a ...... ind, Randomized Phase I Study.
@nl
prefLabel
Safety and Immunogenicity of a ...... ind, Randomized Phase I Study.
@en
Safety and Immunogenicity of a ...... ind, Randomized Phase I Study.
@nl
P2093
P2860
P356
P1476
Safety and Immunogenicity of a ...... lind, Randomized Phase I Study
@en
P2093
Amy Castellano
Chad K Porter
Christopher Duplessis
Claudio Di Paolo
Cristina Alaimo
Hailey E Weerts
Kristen A Clarkson
Kristopher Paolino
Mark S Riddle
Ramiro L Gutierrez
P2860
P304
P356
10.1128/CVI.00224-16
P577
2016-12-05T00:00:00Z